Disappointment With BOJ Sends Markets Plunging

Disappointment with the Bank of Japan's monetary policy sent the markets tumbling to a sharply lower close with the Dow plunging 116 points to 15,122. Nasdaq plummeted 36 points to 3436.

On the upside

A Food and Drug Administration advisory panel will review the constipation treatment Relistor that was developed by Progenics Pharmaceuticals (Nasdaq: PGNX) and Salix Pharmaceuticals (Nasdaq: SLXP).

Baker Bros. increased its stake in Vanda Pharmaceuticals (Nasdaq: VNDA) to 13.99%.

Diamond Foods (NYSE: DMND) narrowed third quarter losses more than expected and appointed Raymond Silcock to the position of executive vice president and chief financial officer.


On the downside


First Solar (Nasdaq: FSLR) announced a public offering of 8.5 million common shares.


Symmetry Medical (NYSE: SMA) forecast second quarter earnings and revenue below analyst expectations and cut its full year guidance.


Workday (NYSE: WDAY) will offer a total of $440 million in convertible senior notes.

In the broad market, declining issues outpaced advancers by a margin of nearly 6 to 1 on the NYSE and by more than to 5 to 2 on Nasdaq. The broader S&P 500 index tumbled 16 points to 1626.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.